DVHGF
Price
$0.18
Change
+$0.04 (+28.57%)
Updated
May 6 closing price
Capitalization
26.68M
JAGX
Price
$3.80
Change
-$0.10 (-2.56%)
Updated
Jun 6, 10:39 AM (EDT)
Capitalization
4.97M
Interact to see
Advertisement

DVHGF vs JAGX

Header iconDVHGF vs JAGX Comparison
Open Charts DVHGF vs JAGXBanner chart's image
Devonian Health Group
Price$0.18
Change+$0.04 (+28.57%)
Volume$500
Capitalization26.68M
Jaguar Health
Price$3.80
Change-$0.10 (-2.56%)
Volume$400
Capitalization4.97M
DVHGF vs JAGX Comparison Chart
Loading...
JAGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DVHGF vs. JAGX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVHGF is a Hold and JAGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (DVHGF: $0.18 vs. JAGX: $3.93)
Brand notoriety: DVHGF and JAGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DVHGF: 21% vs. JAGX: 31%
Market capitalization -- DVHGF: $26.68M vs. JAGX: $4.97M
DVHGF [@Biotechnology] is valued at $26.68M. JAGX’s [@Biotechnology] market capitalization is $4.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DVHGF’s FA Score shows that 0 FA rating(s) are green whileJAGX’s FA Score has 0 green FA rating(s).

  • DVHGF’s FA Score: 0 green, 5 red.
  • JAGX’s FA Score: 0 green, 5 red.
According to our system of comparison, DVHGF is a better buy in the long-term than JAGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JAGX’s TA Score shows that 3 TA indicator(s) are bullish.

  • JAGX’s TA Score: 3 bullish, 6 bearish.

Price Growth

DVHGF (@Biotechnology) experienced а 0.00% price change this week, while JAGX (@Biotechnology) price change was -14.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

JAGX is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DVHGF($26.7M) has a higher market cap than JAGX($4.97M). DVHGF YTD gains are higher at: 35.849 vs. JAGX (-84.436). DVHGF has higher annual earnings (EBITDA): 1.25M vs. JAGX (-29.1M). JAGX has more cash in the bank: 13.3M vs. DVHGF (8.42M). DVHGF has less debt than JAGX: DVHGF (148K) vs JAGX (34.3M). DVHGF has higher revenues than JAGX: DVHGF (29M) vs JAGX (10.5M).
DVHGFJAGXDVHGF / JAGX
Capitalization26.7M4.97M537%
EBITDA1.25M-29.1M-4%
Gain YTD35.849-84.436-42%
P/E RatioN/A0.01-
Revenue29M10.5M276%
Total Cash8.42M13.3M63%
Total Debt148K34.3M0%
FUNDAMENTALS RATINGS
JAGX: Fundamental Ratings
JAGX
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JAGX
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
68%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
JAGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TECS33.300.36
+1.09%
Direxion Daily Technology Bear 3X ETF
FSBD46.650.14
+0.29%
Fidelity Sustainable Core Plus Bond ETF
MUE9.49-0.01
-0.11%
Blackrock Muniholdings Quality Fund II
IXJ85.97-0.14
-0.16%
iShares Global Healthcare ETF
BTO33.92-0.44
-1.29%
John Hancock Financial Opportunities Fund

DVHGF and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVHGF has been loosely correlated with CSPHF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if DVHGF jumps, then CSPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVHGF
1D Price
Change %
DVHGF100%
N/A
CSPHF - DVHGF
38%
Loosely correlated
N/A
WINT - DVHGF
38%
Loosely correlated
-12.79%
JAGX - DVHGF
27%
Poorly correlated
-1.75%
RNAZ - DVHGF
25%
Poorly correlated
-1.89%
HMTXF - DVHGF
21%
Poorly correlated
N/A
More

JAGX and

Correlation & Price change

A.I.dvisor tells us that JAGX and DVHGF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JAGX and DVHGF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAGX
1D Price
Change %
JAGX100%
-1.75%
DVHGF - JAGX
27%
Poorly correlated
N/A
SNPX - JAGX
26%
Poorly correlated
+3.19%
SLNO - JAGX
26%
Poorly correlated
-2.47%
ACET - JAGX
26%
Poorly correlated
-5.25%
NCNA - JAGX
26%
Poorly correlated
-14.75%
More